Xgeva 120mg Solution for Injection

Xgeva 120mg Injection contains Denosumab, a monoclonal antibody that targets RANKL, a protein involved in bone breakdown. By blocking RANKL, it helps reduce bone destruction and the risk of certain skeletal complications.

Key Information

• Active Ingredient: Denosumab
• Strength: 120mg
• Form: Solution for subcutaneous injection
• Uses: Used to prevent skeletal-related complications in adults with cancer that has spread to the bones or multiple myeloma. It may also be used for certain giant cell tumors of the bone and hypercalcemia associated with cancer.
• Administration: Typically administered as a subcutaneous injection by a qualified healthcare professional.
• Common Side Effects: Low blood calcium levels, muscle and bone pain, shortness of breath and diarrhea may occur.
• Important: Calcium and vitamin D supplementation may be recommended during treatment. Patients should also maintain good oral hygiene and inform their healthcare professional about planned dental procedures.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare professional before starting or changing any medication.